- Home
- TKNO vs AVX Comparison
TKNO vs AVX Comparison
Compare TKNO & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKNO | AVX |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.1M | 119.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TKNO | AVX |
|---|---|---|
| Price | $2.01 | $0.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 371.9K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.64 | $530,767.50 |
| Revenue Next Year | $9.73 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.91 | $0.60 |
| 52 Week High | $8.65 | $22.50 |
Technical Indicators
Market Signals| Indicator | TKNO | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 16.20 | 34.86 |
| Support Level | $1.96 | $0.60 |
| Resistance Level | $2.26 | $0.77 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 6.59 | 14.81 |
Price Performance
Historical ComparisonAbout TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.